Resistin is expressed in human hepatocytes and induces insulin resistance

Jun Di; Yong Jin; Yu Zhang; Mei Wu; Ying Sun; Gui Zhang
April 2008
Endocrine (1355008X);Apr2008, Vol. 33 Issue 2, p135
Academic Journal
Abstract  Resistin, known as an adipocyte-specific secretory factor (ADSF), is implicated to modulate insulin resistance in rodents. However, the precise role of this factor for human insulin resistance has remained elusive. Here, we investigate the relationship between human resistin and insulin resistance in hepatocytes and the effect of Metformin on resistin. In this study, the expression of resistin in human hepatocytes and hepatic tissues was examined, and the human resistin eukaryotic expression vector was constructed and stably transfected in HepG2 cells. Data showed that resistin is expressed in human hepatocytes and hepatic tissues. Overexpression of human resistin impaired significantly insulin-stimulated glucose uptake and glycogen synthesis in HepG2 cells. It also decreased the expression of insulin receptor substrate 2 (IRS-2) and c-cbl associated protein (CAP), whereas increased the expression of glycogen synthetase kinase 3β (GSK-3β). The result suggested that human resistin induced insulin resistance in hepatocytes by blocking the two insulin signal transduction pathways of PI-3K/Akt and of CAP/c-cbl. We also concluded that Metformin reversed the effect of resistin and downregulated the expression of resistin in hepatocytes.


Related Articles

  • Metformin Inhibits Expression and Secretion of PEDF in Adipocyte and Hepatocyte via Promoting AMPK Phosphorylation. Shumin Yang; Qiong Lv; Ting Luo; Lulu Liu; Rufei Gao; Shumei Chen; Peng Ye; Qingfeng Cheng; Qifu Li // Mediators of Inflammation;2013, Vol. 2013, p1 

    Objective. Pigment epithelium-derived factor (PEDF) plays an important role in obesity-induced insulin resistance (IR). The study aims to investigate the effect of metformin, a widely used agent to improve IR, on PEDF production both in vivo and in vitro. Methods. SD rats were divided into...

  • NYGGF4 ( PID1) effects on insulin resistance are reversed by metformin in 3T3-L1 adipocytes. Qiu, Jie; Wang, Yu-mei; Shi, Chun-mei; Yue, Hong-ni; Qin, Zhen-Ying; Zhu, Guan-zhong; Cao, Xin-guo; Ji, Chen-bo; Cui, Yan; Guo, Xi-rong // Journal of Bioenergetics & Biomembranes;Dec2012, Vol. 44 Issue 6, p665 

    NYGGF4 (also called PID1) is a recently discovered gene that is involved in obesity-related insulin resistance (IR). We aimed in the present study to further elucidate the effects of NYGGF4 on IR and the underlying mechanisms through using metformin treatment in 3T3-L1 adipocytes. Our data...

  • Hepatocytes Are the Principal Source of Circulating RBP4 in Mice. Thompson, Spencer J.; Sargsyan, Ashot; Seung-Ah Lee; Yuen, Jason J.; Jinjin Cai; Smalling, Rana; Ghyselinck, Norbert; Mark, Manuel; Blaner, William S.; Graham, Timothy E.; Lee, Seung-Ah; Cai, Jinjin // Diabetes;Jan2017, Vol. 66 Issue 1, p58 

    RBP4 is produced mainly by hepatocytes. In type 2 diabetes and obesity, circulating RBP4 is increased and may act systemically to cause insulin resistance and glucose intolerance. Observations that adipocyte RBP4 mRNA increases in parallel with circulating RBP4 in these conditions, whereas liver...

  • Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. Takano, Atsuko; Haruta, Tetsuro; Iwata, Minoru; Usui, Isao; Uno, Tatsuhito; Kawahara, Junko; Ueno, Eiichi; Sasaoka, Toshiyasu; Kobayashi, Masashi; Takano, A; Haruta, T; Iwata, M; Usui, I; Uno, T; Kawahara, J; Ueno, E; Sasaoka, T; Kobayashi, M // Diabetes;Aug2001, Vol. 50 Issue 8, p1891 

    Growth hormone (GH) is well known to induce in vivo insulin resistance. However, the molecular mechanism of GH-induced cellular insulin resistance is largely unknown. In this study, we demonstrated that chronic GH treatment of differentiated 3T3-L1 adipocytes reduces insulin-stimulated...

  • Fructose sugar makes maturing human fat cells fatter and less insulin-sensitive.  // Food Engineering & Ingredients;Jun2010, Vol. 35 Issue 3, p26 

    The article reports on the study lead by Georgina Coade of the University of Bristol in Great Britain that shows that fructose sugar present during maturation process of fat cells can make these cells mature into fat cells and less insulin-sensitive which raises risk of heart disease and diabetes.

  • Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance. Olsson, Urban; Egnell, Ann-Charlotte; Lee, Mariam Rodriguez; Lunden, Gunnel Ostergren; Lorentzon, Malin; Salmivirta, Markku; Bondjers, Goran; Camejo, German; Olsson, U; Egnell, A C; Lee, M R; Lundén, G O; Lorentzon, M; Salmivirta, M; Bondjers, G; Camejo, G // Diabetes;Sep2001, Vol. 50 Issue 9, p2126 

    Insulin resistance and type 2 diabetes are associated with elevated circulating levels of insulin, nonesterified fatty acids (NEFAs), and lipoprotein remnants. Extracellular matrix proteoglycan (PG) alterations are also common in macro- and microvascular complications of type 2 diabetes. In...

  • Safety and Efficacy of Pioglitazone/Metformin Combination Therapy in Treatment of Type 2 Diabetes: A Rationale for Earlier Use. Stolar, Mark // Clinical Medicine: Therapeutics;2009, Issue 1, p289 

    Although multiple new agents for the management of diabetes have become available in the past decade, less than 50% of diabetics in the United States have Hgb A-1-C levels below 7.0% and far fewer at the newer more stringent targets of 6.0% to 6.5%. It has become increasingly clear that the...

  • Metabolic Syndrome and Robustness Tradeoffs. Kitano, Hiroaki; Oda, Kanae; Kimura, Tomomi; Matsuoka, Yukiko; Csete, Marie; Doyle, John; Muramatsu, Masaaki // Diabetes;Dec2004 Supplement, Vol. 53, pS6 

    The metabolic syndrome is a highly complex breakdown of normal physiology characterized by obesity, insulin resistance, hyperlipidemia, and hypertension. Type 2 diabetes is a major manifestation of this syndrome, although increased risk for cardiovascular disease (CVD) often precedes the onset...

  • Common Genetic Variation in the SERPINF1 Locus Determines Overall Adiposity, Obesity-Related Insulin Resistance, and Circulating Leptin Levels. B�hm, Anja; Ordelheide, Anna-Maria; Machann, J�rgen; Heni, Martin; Ketterer, Caroline; Machicao, Fausto; Schick, Fritz; Stefan, Norbert; Fritsche, Andreas; H�ring, Hans-Ulrich; Staiger, Harald // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Objective: Pigment epithelium-derived factor (PEDF) belongs to the serpin family of peptidase inhibitors (serpin F1) and is among the most abundant glycoproteins secreted by adipocytes. In vitro and mouse in vivo data revealed PEDF as a candidate mediator of obesity-induced insulin resistance....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics